ATYPICAL HEMOLYTIC SYNDROME INDUCED BY PEMBROLIZUMAB. MANAGEMENT AND OUTCOMES.
Back
E-Poster
https://storage.unitedwebnetwork.com/files/1099/14d9782163f13f9204638185846aea72.pdf
Abstract Title
ATYPICAL HEMOLYTIC SYNDROME INDUCED BY PEMBROLIZUMAB. MANAGEMENT AND OUTCOMES.
First Name *
Natallia
Last Name *
Maroz
Co-author 1
Ashantice Higgins ashantice.higgins@wright.edu Wright State University/Kettering Health Internal Medicine/Hematology and Oncology Dayton
Co-author 2
John Harcha john.harcha@ketteringhealth.org Kettering Health Internal Medicine/Hematology and Oncology Dayton
Co-author 3
Kelsey Marshall kelsey.marshall@ketteringhealth.org Kettering Health Internal Medicine/Hematology and Oncology Dayton
Co-author 4
Derek Jernigan derek.jernigan@ketteringhealth.org Kettering Health Internal Medicine Dayton
Co-author 5
Co-author 6
Co-author 7
Co-author 8
Co-author 9
Co-author 10
Co-author 11
Co-author 12
Co-author 13
Co-author 14
Co-author 15
E-Poster Format Requirements
PDF file
Layout: Portrait (vertical orientation)
One page only (Dim A4: 210 x 297mm or PPT)
E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but
must be saved and submitted as PDF file
.
File Size: Maximum file size is 2 Megabytes (2 MB)
No hyperlinks, animated images, animations, and slide transitions
Language: English
Include your abstract number
E-posters can include QR codes, tables and photos